🇺🇸 FDA
Pipeline program

SELUMETINIB, CASODEX 50 mg compresse rivestite con film, OLAPARIB

Phase 2 small_molecule active

Quick answer

SELUMETINIB, CASODEX 50 mg compresse rivestite con film, OLAPARIB for Metastatic breast cancer is a Phase 2 program (small_molecule) at Istituto Gentili S.r.l. with 1 ClinicalTrials.gov record(s).

Program details

Company
Istituto Gentili S.r.l.
Indication
Metastatic breast cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials